Jake T. Liang - Concepedia

Author

Jake T. Liang

National Institute of Diabetes and Digestive and Kidney Diseases

Also Known As

J. Liang, Jake Liang, Jake T Liang, Jake T. Liang

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health National Cancer Institute Harvard University Massachusetts General Hospital

About

Jake T. Liang is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in hepatology, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	942
2	Hepatology	5	5	942
3	Immunology	3	3	574
4	Health Sciences	1	1	280
5	Epidemiology	1	1	280

Jake T. Liang

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Hepatitis B: The virus and disease # Jake T. Liang Hepatology	2009	1.1K
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡ Kittichai Promrat, Glen Lutchman, Gabriel I. Uwaifo, Hepatology	2004	723
The Association of Genetic Variability in Patatin-Like Phospholipase Domain-Containing Protein 3 (PNPLA3) with Histological Severity of Nonalcoholic Fatty Liver Disease† Yaron Rotman, Christopher Koh, Joseph M. Zmuda, Hepatology	2010	469
Long-term therapy of chronic hepatitis B with lamivudine Daryl Lau, Farooq Khokhar, Edward Doo, Hepatology ImmunologyHepatitis BPathologyChronic Hepatitis BPharmacotherapy	2000	350
Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis Apurva A. Modi, Jordan J. Feld, Yoon Park, Hepatology NutritionFatty Liver DiseaseMetabolic SyndromeViral HepatitisHepatotoxicity	2009	280
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response Jordan J. Feld, Santosh Kumar Nanda, Ying Huang, Hepatology	2007	263
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C Alejandro Soza, James E. Everhart, Marc G. Ghany, Hepatology	2002	214
Hepatocyte NAD(P)H Oxidases as an Endogenous Source of Reactive Oxygen Species During Hepatitis C Virus Infection Nabora Soledad Reyes de Mochel, Scott Seronello, Shelley Hsiuying Wang, Hepatology	2010	182
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models Emmanuel Thomas, Jordan J. Feld, Qisheng Li, Hepatology	2010	150
Effects of antiviral therapy on the cellular immune response in acute hepatitis C Fareed Rahman, Theo Heller, Yuji Sobao, Hepatology ImmunologyCd4 T Cell ResponsesHcv PeptidesAntiviral DrugImmunotherapy	2004	133

Page 1